BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4697358)

  • 1. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
    Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
    J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.
    Temple TE; Jones DJ; Liddle GW; Dexter RN
    N Engl J Med; 1969 Oct; 281(15):801-5. PubMed ID: 4309238
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome in the dog.
    Kelly DF; Darke PG
    Vet Rec; 1976 Jan; 98(2):28-30. PubMed ID: 769295
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Mar; 182(5):506-10. PubMed ID: 6300008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cushing's syndrome].
    Geyer G
    Ann N Y Acad Sci; 1973 Jun; 214():614-9. PubMed ID: 4593436
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases.
    Luton JP; Mahoudeau JA; Bouchard P; Thieblot P; Hautecouverture M; Simon D; Laudat MH; Touitou Y; Bricaire H
    N Engl J Med; 1979 Mar; 300(9):459-64. PubMed ID: 215912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's syndrome in the dog.
    Siegel ET; Kelly DF; Berg P
    J Am Vet Med Assoc; 1970 Dec; 157(12):2081-90. PubMed ID: 4320508
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.
    Faggiano A; Leboulleux S; Young J; Schlumberger M; Baudin E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):110-3. PubMed ID: 16402938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of o,p'DDD on human adrenal steroid 11 beta-hydroxylation activity.
    Brown RD; Nicholson WE; Chick WT; Strott CA
    J Clin Endocrinol Metab; 1973 Apr; 36(4):730-3. PubMed ID: 4686378
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperadrenocorticism in the dog: canine Cushing's syndrome.
    Owens JM; Drucker WD
    Vet Clin North Am; 1977 Aug; 7(3):583-602. PubMed ID: 198937
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment of Cushing's disease.
    N Engl J Med; 1969 Oct; 281(15):846-7. PubMed ID: 5809521
    [No Abstract]   [Full Text] [Related]  

  • 14. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
    Hermus AR; Pieters GF; Smals AG; Pesman GJ; Lamberts SW; Benraad TJ; van Haelst UJ; Kloppenborg PW
    N Engl J Med; 1988 Apr; 318(15):966-70. PubMed ID: 2832758
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics.
    Lothrop CD; Oliver JW
    Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's syndrome in a dog.
    Feldman EC; Tyrrell JB; Ettinger SJ
    Mod Vet Pract; 1977 Dec; 58(12):995-9. PubMed ID: 201827
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal ACTH and plasma cortisol variations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid.
    Castillo VA; Cabrera Blatter MF; Gómez NV; Sinatra V; Gallelli MF; Ghersevich MC
    Res Vet Sci; 2009 Apr; 86(2):223-9. PubMed ID: 18692856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
    Reusch C; Hähnle B
    Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.